Take Our New Survey on FDA-Pharma Manufacturer Relations

Nov. 13, 2006

We invite you to share your views on how the FDA's move to risk- and science-based regulation is changing plant inspections, interactions with the Agency, and drug manufacturing in general. Ten respondents, selected at random, will earn $50 Starbucks gift cards.

The U.S. Food and Drug Administration (FDA) has moved from a "command and control" approach to regulation, to one guided by the principles of risk management. The Agency is also encouraging drug manufacturers to embrace the principles of science-based manufacturing, quality systems and Quality by Design. This survey will examine how, and whether, this new approach is changing day-to-day interactions and plant inspections. Please take 10 minutes to complete the survey; results will be interpreted in January's issue of Pharmaceutical Manufacturing and on our web site.

Click here to take survey

Take Our New Survey on FDA-Pharma Manufacturer Relations

Latest from cGMPs

Compliance fire drill: Mock FDA audits for cleaning validation

White paper: Enhancing virus clearance process capability using a biodegradable detergent

Key considerations for CGMP raw materials compliance

Intas hit with FDA warning letter

Beyond ‘good’ practices

Biocon hit with multiple 483s